scispace - formally typeset
R

Rutger J. Hassink

Researcher at Utrecht University

Publications -  31
Citations -  996

Rutger J. Hassink is an academic researcher from Utrecht University. The author has contributed to research in topics: Atrial fibrillation & Catheter ablation. The author has an hindex of 10, co-authored 31 publications receiving 840 citations. Previous affiliations of Rutger J. Hassink include University of Groningen.

Papers
More filters
Journal ArticleDOI

Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures.

TL;DR: A striking inverse relationship between cardiomyocyte differentiation and the concentration of FCS is demonstrated during HES‐2‐END‐2 coculture, and this model represents an improved in vitro model, without interfering factors in serum, for testing other factors that might promote cardiomeocyte differentiation.
Journal ArticleDOI

The human adult cardiomyocyte phenotype.

TL;DR: Characterization of the redifferentiation capabilities of cultured adult cardiac myocytes in culture provides an important system for comparing cardiomyocytes differentiating from human stem cells and provides the basis for an in vitro transplantation model to study interaction and communication between primary adult and stem cell-derived cardiomeocytes.
Journal ArticleDOI

Quality of life in patients with paroxysmal atrial fibrillation and its predictors: importance of the autonomic nervous system.

TL;DR: This study shows that paroxysmal atrial fibrillation causes significant impairment of quality of life, and symptomatology and autonomic function are important predictors ofquality of life in this patient group.
Journal ArticleDOI

Incidence of Pulmonary Vein Stenosis After Radiofrequency Catheter Ablation of Atrial Fibrillation

TL;DR: It seems appropriate to only screen for PVS in patients with suggestive symptoms after RFCA of atrial fibrillation, as incidence of severe PVS was <1% and incidence of symptomatic PVS necessitating intervention was negligible.
Journal ArticleDOI

Five-year efficacy of pulmonary vein antrum isolation as a primary ablation strategy for atrial fibrillation: a single-centre cohort study

TL;DR: Five-year freedom of atrial tachyarrhythmia could be achieved by PVAI as primary ablation strategy in 58.3% of patients, and independent predictors for arrhythmic recurrence were non-paroxysmal AF, female sex, body mass index, hypertension, and AF duration.